Home/Pipeline/Melatobel Tablet 1 mg/2 mg

Melatobel Tablet 1 mg/2 mg

Pediatric Sleep Disorders

CommercialMarketed in Japan

Key Facts

Indication
Pediatric Sleep Disorders
Phase
Commercial
Status
Marketed in Japan
Company

About Nobelpharma

Japanese pharmaceutical company developing critical but neglected drugs and medical devices for rare diseases and pediatric conditions.

View full company profile

Other Pediatric Sleep Disorders Drugs

DrugCompanyPhase
Melatobel® Granules for Pediatric Use 0.2%NobelpharmaCommercial